Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:979-980 (29 October), doi:10.1136/bmj.331.7523.979
Needs to be compared with other interventions
| The first 150 words of the full text of this article appear below. |
Near patient testing (at the point of care) is a term used to describe investigations done in clinical settings that yield results available immediately without the need for a laboratory.1 Until now, near patient testing has been used mainly for diagnosis, such as for urine analysis, and for monitoring conditions such as diabetes or response to treatments such as warfarin.1 In addition, measurements of carbon monoxide in expired air are used to monitor smoking cessation, but this has not been evaluated fully. In this week's BMJ Barnfather and colleagues report the results of a randomised controlled trial in which a near patient test for nicotine metabolites in saliva was used to encourage smoking cessation by dental patients.2
For each trial participant, the saliva test produced a single numerical result relating to the salivary cotinine concentration and showing how heavily the person smoked. In all, 100 smokers took the saliva
Tim Coleman, senior lecturer in general practice
Division of Primary Care, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH (tim.coleman@nottingham.ac.uk)